GlassScriptPhysician profile
Dale Helman
NPI 1407926009
$20,093.00
in general payments reported to CMS, 2019-2025
70 companies · $2,590 in 2025
The $2,590 reported for 2025 was more than what 77% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,348 · 2020: $2,575 · 2021: $3,629 · 2022: $2,852 · 2023: $2,842 · 2024: $3,257 · 2025: $2,590.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,579 · Education: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,578.78 |
| Education | $110.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,136.01 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $2,131.54 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Biogen, INC. | $1,990.63 | 2019-2025 | Vumerity, Tysabri, Plegridy |
| Ucb, INC. | $1,089.74 | 2019-2024 | Rystiggo, Briviact |
| Neurocrine Biosciences, INC. | $801.51 | 2019-2025 | Ingrezza, Ongentys |
| Pfizer INC. | $773.14 | 2019-2025 | |
| Celgene Corporation | $686.84 | 2021-2024 | Zeposia |
| Adamas Pharmaceuticals, INC. | $651.87 | 2019-2021 | |
| Eisai INC. | $631.63 | 2021-2025 | |
| Lilly USA, LLC | $627.42 | 2019-2025 | Amyvid, Kisunla, Emgality |
| Kyowa Kirin, INC. | $535.70 | 2019-2024 | Nourianz |
| Acorda Therapeutics, INC | $495.89 | 2022-2024 | Inbrija, Ampyra |
| Livanova USA, INC. | $488.35 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Lundbeck LLC | $451.04 | 2019-2025 | Vyepti, Rexulti |
| Allergan, INC. | $391.99 | 2019-2022 |
Show all 70 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dale Helman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.